Form 4 · Filed Jun 24, 2026, 11:22 PM UTC
NBP/NovaBridge Biosciences
Cao Sean Wuxiong — Chief Bus. Development Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | A | other | 181,280 | — | — | 181,280 |
| Jun 22, 2026 | A | other | 181,290 | — | — | 181,290 |
Source: SEC EDGAR raw filing ↗ · Accession 0002109966-26-000004